Deutsche Bank Ag\ Arcturus Therapeutics Holdings Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 17,351 shares of ARCT stock, worth $257,488. This represents 0.0% of its overall portfolio holdings.

Number of Shares

17,351

Previous 29,670 41.52%

Holding current value

$257,488

Previous $722,000 44.32%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$18.08 - $25.38 $222,727 - $312,656	-12,319 Reduced 41.52%	17,351 $402,000
Q2 2024 Aug 14, 2024	SELL	$24.35 - $44.39 $31,070 - $56,641	-1,276 Reduced 4.12%	29,670 $722,000
Q1 2024 May 15, 2024	BUY	$31.23 - $42.99 $24,140 - $33,231	773 Added 2.56%	30,946 $1.05 Million
Q4 2023 Feb 14, 2024	SELL	$17.71 - $32.97 $4,480 - $8,341	-253 Reduced 0.83%	30,173 $951,000
Q3 2023 Nov 09, 2023	SELL	$25.44 - $37.35 $182,150 - $267,426	-7,160 Reduced 19.05%	30,426 $777,000
Q2 2023 Aug 14, 2023	SELL	$23.94 - $32.36 $155,226 - $209,822	-6,484 Reduced 14.71%	37,586 $1.08 Million
Q1 2023 May 15, 2023	BUY	$14.72 - $23.97 $61,662 - $100,410	4,189 Added 10.5%	44,070 $1.06 Million
Q4 2022 Feb 13, 2023	BUY	$14.14 - $23.06 $414,302 - $675,658	29,300 Added 276.91%	39,881 $676,000
Q3 2022 Nov 14, 2022	SELL	$13.05 - $22.13 $36,957 - $62,672	-2,832 Reduced 21.11%	10,581 $157,000
Q2 2022 Aug 11, 2022	SELL	$12.26 - $31.17 $129,159 - $328,375	-10,535 Reduced 43.99%	13,413 $210,000
Q1 2022 May 13, 2022	BUY	$17.64 - $39.57 $4,604 - $10,327	261 Added 1.1%	23,948 $645,000
Q4 2021 Feb 11, 2022	BUY	$34.2 - $47.56 $105,028 - $146,056	3,071 Added 14.9%	23,687 $877,000
Q3 2021 Nov 04, 2021	SELL	$27.88 - $58.25 $5,157 - $10,776	-185 Reduced 0.89%	20,616 $985,000
Q2 2021 Aug 11, 2021	BUY	$25.79 - $42.11 $35,383 - $57,774	1,372 Added 7.06%	20,801 $704,000
Q1 2021 May 13, 2021	BUY	$38.75 - $86.92 $43,283 - $97,089	1,117 Added 6.1%	19,429 $802,000
Q4 2020 Feb 16, 2021	BUY	$34.61 - $123.66 $280,860 - $1 Million	8,115 Added 79.58%	18,312 $794,000
Q3 2020 Nov 12, 2020	SELL	$37.49 - $63.19 $19.2 Million - $32.3 Million	-511,470 Reduced 98.05%	10,197 $438,000
Q2 2020 Aug 13, 2020	BUY	$12.66 - $58.27 $6.6 Million - $30.4 Million	521,667 New	521,667 $24.4 Million
Q1 2020 May 14, 2020	SELL	$9.31 - $18.26 $39,139 - $76,765	-4,204 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$8.93 - $12.41 $37,113 - $51,575	4,156 Added 8658.33%	4,204 $45,000
Q3 2019 Nov 14, 2019	BUY	$8.8 - $14.5 $422 - $696	48 New	48 $0

Others Institutions Holding ARCT

# of Institutions

179

Shares Held

25.6M

Call Options Held

195K

Put Options Held

133K

View Full List

About Arcturus Therapeutics Holdings Inc.

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $394M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

More about ARCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account